{"nctId":"NCT04560309","briefTitle":"Role of Glutamine as Myocardial Protector in Elective On-Pump CABG Surgery With Low EF","startDateStruct":{"date":"2021-01-01","type":"ACTUAL"},"conditions":["Coronary Artery Bypass","Cardiopulmonary Bypass","Coronary Artery Disease"],"count":60,"armGroups":[{"label":"Glutamine","type":"EXPERIMENTAL","interventionNames":["Drug: L-alanyl-L-glutamine dipeptide"]},{"label":"Control","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]}],"interventions":[{"name":"L-alanyl-L-glutamine dipeptide","otherNames":["Dipeptiven"]},{"name":"Placebo","otherNames":["Normal saline"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Patients with coronary heart disease indicated for elective coronary artery bypass grafting under cardiopulmonary bypass\n* Patients with left ventricle ejection fraction 31% -50% confirmed by echocardiography or radio nuclear study.\n* Patients age ≥18 years\n* Never had heart surgery before\n* Agree to participate in the study and signed informed consent\n\nExclusion Criteria:\n\n* Emergency coronary artery grafting bypass\n* Having additional procedures other than coronary artery bypass grafting\n* History of myocardial infarction with onset less than 3 months\n* Patients with serum creatinine level more than 2 g/dL\n* Patients with ALT/AST levels more than 1.5 times the upper limit of normal value\n* Required to use intra-aortic balloon pump pre-operatively\n* History of stroke with onset less than 3 months\n* History of pre-operative atrial fibrillation\n* History of heart conduction problem and/or using a pacemaker\n* Patients with HIV\n* Contraindications to pulmonary artery catheter insertion\n\nDrop out Criteria\n\n* Experiencing stroke after surgery\n* Experiencing surgery related complication (haemorrhage) requiring re operation\n* Requiring continuous veno-venous hemofiltration or haemodialysis after surgery\n* Delayed sternal closure\n* Aortic cross clamp duration more than 120 minutes and/or cardiopulmonary bypass time more than 180 minutes","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Plasma Troponin I at Baseline","description":"Plasma troponin I were measured using enzyme immunoassay (ELISA) in unit of ng/mL","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.42","spread":null},{"groupId":"OG001","value":"0.17","spread":null}]}]}]},{"type":"PRIMARY","title":"Plasma Troponin I at 5 Minute After Cardiopulmonary Bypass","description":"Plasma troponin I were measured using enzyme immunoassay (ELISA) in unit of ng/mL","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.72","spread":"0.98"},{"groupId":"OG001","value":"1.68","spread":"1.10"}]}]}]},{"type":"PRIMARY","title":"Plasma Troponin I at 6 Hour After Cardiopulmonary Bypass","description":"Plasma troponin I were measured using enzyme immunoassay (ELISA) in unit of ng/mL","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.43","spread":"1.51"},{"groupId":"OG001","value":"4.41","spread":"1.89"}]}]}]},{"type":"PRIMARY","title":"Plasma Troponin I at 24 Hour After Cardiopulmonary Bypass","description":"Plasma troponin I were measured using enzyme immunoassay (ELISA) in unit of ng/mL","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.08","spread":null},{"groupId":"OG001","value":"3.77","spread":null}]}]}]},{"type":"PRIMARY","title":"Plasma Troponin I at 48 Hour After Cardiopulmonary Bypass","description":"Plasma troponin I were measured using enzyme immunoassay (ELISA) in unit of ng/mL","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.66","spread":null},{"groupId":"OG001","value":"1.75","spread":null}]}]}]},{"type":"PRIMARY","title":"Plasma Glutamine at Baseline","description":"Plasma glutamine were measured using colorimetric tests in unit of µmol/L","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"555.09","spread":"198.16"},{"groupId":"OG001","value":"632.24","spread":"266.36"}]}]}]},{"type":"PRIMARY","title":"Plasma Glutamine at 24 Hour After Cardiopulmonary Bypass","description":"Plasma glutamine were measured using colorimetric tests in unit of µmol/L","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"935.42","spread":"319.10"},{"groupId":"OG001","value":"634.79","spread":"243.89"}]}]}]},{"type":"SECONDARY","title":"Right Atrial Appendage Alpha-ketoglutarate","description":"Right atrial appendage alpha-ketoglutarate were measured from right atrial appendage tissue biopsy using colorimetric tests in unit of g/mol.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"674.93","spread":"333.49"},{"groupId":"OG001","value":"507.32","spread":"280.79"}]}]}]},{"type":"SECONDARY","title":"Right Atrial Appendage Myocardial Injury Score","description":"Right atrial appendage myocardial injury score were measured from tissue section stained with hematoxylin-eosin and examined under by light microscopy in score of 0 (no change) to 3 (major changes with necrosis and diffuse inflammation). Higher scores mean worse outcome","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.30","spread":"0.24"},{"groupId":"OG001","value":"1.48","spread":"0.26"}]}]}]},{"type":"SECONDARY","title":"Right Atrial Appendage Apoptosis Index","description":"Right atrial appendage apoptosis index were measured from tissue section stained with in situ terminal deoxynucleotidyl transferase dUTP nick end labelling (TUNEL) and examined under light microscopy in average number of apoptotic cells (positively stained) from 6 random fields per section","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5.00","spread":null},{"groupId":"OG001","value":"6.17","spread":null}]}]}]},{"type":"SECONDARY","title":"Anti Cardiac Troponin I Expression","description":"Right atrial appendage anti cardiac troponin I expression were measured from tissue section stained with anti-cardiac troponin I antibody and examined under light microscopy in score of 0 (no change) to -3 (no area observed with anti-cardiac troponin I expression). Higher score mean better outcome","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.33","spread":null},{"groupId":"OG001","value":"-0.83","spread":null}]}]}]},{"type":"SECONDARY","title":"Ejection Fraction","description":"Ejection fraction were measured by transesophageal echocardiography using Simpson method in percentage (%)","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"41.40","spread":null},{"groupId":"OG001","value":"41.60","spread":null}]}]}]},{"type":"SECONDARY","title":"Ejection Fraction","description":"Ejection fraction were measured by transesophageal echocardiography using Simpson method in percentage (%)","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"46.17","spread":"5.15"},{"groupId":"OG001","value":"45.55","spread":"5.03"}]}]}]},{"type":"SECONDARY","title":"Cardiac Index","description":"Cardiac index were measured from pulmonary artery catheter using thermodilution method in unit of L/min/m\\^2","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.00","spread":"0.58"},{"groupId":"OG001","value":"1.87","spread":"0.35"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.15","spread":"0.57"},{"groupId":"OG001","value":"3.03","spread":"0.38"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.45","spread":"0.55"},{"groupId":"OG001","value":"2.36","spread":"0.56"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.54","spread":"0.45"},{"groupId":"OG001","value":"2.27","spread":"0.40"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.68","spread":"0.35"},{"groupId":"OG001","value":"2.47","spread":"0.41"}]}]}]},{"type":"SECONDARY","title":"Plasma Lactate Before Induction to Anesthesia","description":"Plasma lactate were measured using enzymatic method by blood gas analyser machine in unit of mmol/L","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.40","spread":null},{"groupId":"OG001","value":"1.30","spread":null}]}]}]},{"type":"SECONDARY","title":"Plasma Lactate 5 Minute After Cardiopulmonary Bypass","description":"Plasma lactate were measured using enzymatic method by blood gas analyser machine in unit of mmol/L","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.02","spread":"0.53"},{"groupId":"OG001","value":"2.08","spread":"0.62"}]}]}]},{"type":"SECONDARY","title":"Plasma Lactate 6 Hours After Cardiopulmonary Bypass","description":"Plasma lactate were measured using enzymatic method by blood gas analyser machine in unit of mmol/L","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5.30","spread":null},{"groupId":"OG001","value":"5.70","spread":null}]}]}]},{"type":"SECONDARY","title":"Plasma Lactate 24 Hours After Cardiopulmonary Bypass","description":"Plasma lactate were measured using enzymatic method by blood gas analyser machine in unit of mmol/L","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.08","spread":"0.67"},{"groupId":"OG001","value":"2.46","spread":"0.69"}]}]}]},{"type":"SECONDARY","title":"Plasma Lactate 48 Hours After Cardiopulmonary Bypass","description":"Plasma lactate were measured using enzymatic method by blood gas analyser machine in unit of mmol/L","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.13","spread":"0.63"},{"groupId":"OG001","value":"2.28","spread":"0.61"}]}]}]},{"type":"SECONDARY","title":"Intensive Care Unit Ventilation Time","description":"Intensive care unit ventilation time were measured from length of time participant was on ventilator in intensive care unit in minutes.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"652.82","spread":"195.09"},{"groupId":"OG001","value":"656.82","spread":"277.07"}]}]}]},{"type":"SECONDARY","title":"Intensive Care Unit Length of Stay","description":"Intensive care unit length of stay were measured from length of time participant spent in intensive care unit in unit of hours","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"20.00","spread":null},{"groupId":"OG001","value":"20.00","spread":null}]}]}]},{"type":"SECONDARY","title":"Vasoactive Inotropic Score","description":"Vasoactive inotropic score (VIS) were maximum vasoactive and inotropic dose required by participant after surgery measured by VIS=dopamine dose in mg/kgbw/min + dobutamine dose in mg/kgbw/min + 100 x epinephrine dose in mg/kgbw/min + 10 x milrinone dose in mcg/kgbw/min + 10.000 x vasopressin dose in units/kgbw/min + 100 x norepinephrine dose in mcg/kgbw/min. Higher scores means worse outcomes. VIS \\>= 20 is considered as high VIS and is associated with poor outcomes.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5.00","spread":null},{"groupId":"OG001","value":"5.00","spread":null}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Coronary Graft","description":"Number of coronary arteries grafted during operation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.00","spread":null},{"groupId":"OG001","value":"3.00","spread":null}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Total Surgical Procedure Time","description":"Total time taken for the surgical procedure. Measured in minutes.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"225.79","spread":"45.60"},{"groupId":"OG001","value":"214.48","spread":"50.13"}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Cardiopulmonary Bypass Time","description":"Total time measured the patient went under cardiopulmonary bypass. Measured in minutes.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"87.00","spread":null},{"groupId":"OG001","value":"78.00","spread":null}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Aortic Cross-clamping Time","description":"Total time the patient underwent aortic cross-clamping during the surgical procedure. Measured in minutes.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"44.38","spread":"9.07"},{"groupId":"OG001","value":"43.86","spread":"14.81"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":30},"commonTop":[]}}}